Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Lilly

Patients Lost More Weight On Eli Lilly's Mounjaro Than Novo Nordisk's Ozempic

Patients lost more significantly more weight on Eli Lilly's Mounjaro than Novo Nordisk's Ozempic, according to a new study.

Investors Business Daily

A weight loss miracle! New shot does better than Ozempic and Wegovy during trials

Tirzepatide, which is sold under the brand names Mounjaro and Zepbound – which treat diabetes and weight loss, respectively – leads to more weight loss than semaglutide, new research has shown

The Independent UK

Eli Lilly Snaps Up Morphic For $3.2 Billion; Morphic Stock Hits The Stratosphere

Eli Lilly said Monday it would acquire Morphic Holding for $3.2 billion, and Morphic stock skyrocketed to a 10-month high.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

What Is Kisunla? Know All About New FDA-Approved Drug For Alzheimer's Disease

Kisunla manufactured by Eli Lilly could significantly slow cognitive decline in people with early symptomatic Alzheimer's disease, according to results of the company's clinical trials.

Medical Daily

FDA Approves New Alzheimer's Drug To Slow Disease Progression

FDA approves Eli Lilly's donanemab for early Alzheimer's, offering hope for patients and caregivers. Treatment priced at 5 per vial.

Top News

FDA approves second Alzheimer’s drug that can slow onset of disease

Eli Lilly says Kisunla demonstrated ‘meaningful results’ for people showing early symptoms of the disease

The Guardian - US

Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug

Eli Lilly won FDA approval for its Alzheimer's treatment, donanemab, on Tuesday. But Eli Lilly stock remained in the red.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Novo, Lilly Fall After Biden Slams Duo For 'Unconscionably High' Drug Prices

Novo Nordisk stock fell Tuesday after Joe Biden and Bernie Sanders slammed the drugmaker and Eli Lilly for high prices of weight-loss drugs.

Investors Business Daily

FDA approves a second Alzheimer's drug that can modestly slow disease

U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease

The Independent UK

Amazon, Meta Spearhead Fresh Batch Of Breakouts As Nvidia Shows Resilience

As Nvidia tests support, Amazon breaks out and Meta moves toward a new buy point, IBD Leaderboard highlights more breakouts.

Investors Business Daily

3 Mega-Cap Stocks to Consider Before They're Worth $1 Trillion

Mega-cap stocks are the flavor of the season, and these three big names are the next set of contenders racing towards the $1 trillion market cap club.

Barchart

Eli Lilly Option Trade Could Make $4,000 With A Pullback

This broken wing butterfly trade has a profit zone between 810 and 890.

Investors Business Daily

Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again

ResMed stock and Inspire Medical Systems stock tumbled Monday after Eli Lilly said its weight-loss drug reduced sleep apnea events.

Investors Business Daily

Weight loss drug could ease sleep apnoea in people with obesity, study says

Research raises possibility that tirzepatide could become first pharmaceutical treatment for the sleeping disorder

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs

The World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines

Investors Business Daily

Top Weight-Loss Rivals Share This Risk After Eye-Popping Runs

Investors Business Daily

Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower

Eli Lilly stock seesawed Tuesday after a Food and Drug Administration panel endorsed its Alzheimer's treatment, donanemab.

The Independent UK

Alzheimer's drug that can slow disease gets backing from FDA advisers

Federal health advisers have endorsed a closely watched Alzheimer’s drug from Eli Lilly for people with mild dementia

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

FDA Panelists Unanimously Back Eli Lilly's Biogen-Rivaling Alzheimer's Drug

Eli Lilly stock jumped Monday after FDA advisors said the benefits of Alzheimer's treatment donanemab outweigh the risks for most patients.

Fortune

Should a CFO switch industries? For these Fortune 500 finance chiefs, a new sector provided a career boost

Most CFOs have more options than they think, according to an expert.

Fortune

Alphabet’s next CFO Anat Ashkenazi ‘fills a void’ for the company at key time during AI Revolution, says top analyst

Ashkenazi is a 23-year veteran of Eli Lilly and Company.

Investors Business Daily

Mutual Funds Keep Buying Up Google, These 2 Other Big Caps

Google stock is a mutual fund favorite and is near a buy point. Two other leading growth stocks top the list of fund favorites.

Investors Business Daily

Madrigal, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH

Madrigal stock plummeted Wednesday on detailed results from a study of Eli Lilly's weight-loss drug in patients with a serious liver disease.

Fortune

Google and Alphabet’s new CFO is Eli Lilly’s Anat Ashkenazi

Ashkenazi will have the task of investing in the company’s next wave of growth in the AI era.

Investors Business Daily

Costco, Eli Lilly Near New Highs; That Doesn't Scare Mutual Funds

Costco stock is in a buy zone ahead of the earnings report Thursday. Mutual funds like this stock and a few others.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations